A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study

Orphanet Journal of Rare Diseases

Volumn 7, Issue 1, 2012, Pages

  Pierucci, Paola ^a,b   Lenato, Gennaro M ^a   Suppressa, Patrizia ^a   Lastella, Patrizia ^a   Triggiani, Vincenzo ^c   Valerio, Raffaella ^a   Comelli, Mario ^b   Salvante, Daniela ^d   Stella, Alessandro ^a   Resta, Nicoletta ^a   Logroscino, Giancarlo ^c   Resta, Francesco ^a   Sabb, Carlo ^a,c  

^a POLICLINICO   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d Apulia Regional Health Agency   (Italy)

Author keywords

Diagnostic delay; Hereditary haemorrhagic telangiectasia; Rare disease; Rendu Osler Weber disorder; Vascular malformations

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC DELAY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PATIENT REFERRAL; QUESTIONNAIRE; RENDU OSLER WEBER DISEASE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ARTERIOVENOUS MALFORMATIONS; CHILD; DELAYED DIAGNOSIS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; QUESTIONNAIRES; RARE DISEASES; RETROSPECTIVE STUDIES; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; YOUNG ADULT;

EID: 84861888864     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-7-33     Document Type: Article

References (34)

1. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, Nozaki J, Inoue S, Koizumi A, Hum Mutat 2002 19 140 148 10.1002/humu.10026 11793473 (Pubitemid 34121805)
2. Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Begbie ME, Wallace GM, Shovlin CL, Postgrad Med J 2003 79 18 24 10.1136/pmj.79.927.18 12566546 (Pubitemid 36237873)
3. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. Abdalla SA, Letarte M, J Med Genet 2006 43 97 110 15879500 (Pubitemid 43262964)
4. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Shovlin CL, Blood Rev 2010 24 203 219 10.1016/j.blre.2010.07.001 20870325
5. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. Cole SG, Begbie ME, Wallace GM, Shovlin CL, J Med Genet 2005 42 577 582 10.1136/jmg.2004.028712 15994879 (Pubitemid 40993833)
6. Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians. Bayrak-Toydemir P, Mao R, Lewin S, McDonald J, Genet Med 2004 6 175 191 10.1097/01.GIM.0000132689.25644.7C 15266205 (Pubitemid 39005857)
7. Hereditary hemorrhagic telangiectasia: children need screening too. Sekarski LA, Spangenberg LA, Pediatr Nurs 2011 37 163 168 21916343
8. An update on autoinflammatory diseases. New concepts for new and old diseases. Gattorno M, La Regina M, Martini A, Manna R, Clin Exp Rheumatol 2009 27 354 365 19473583
9. Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient. Shook SJ, Pioro EP, Ann Neurol 2009 65 Suppl 1 10 s16 19191305
10. Clinical characteristics of subjects with symptoms of alpha1-antitrypsin deficiency older than 60 years. Campos MA, Alazami S, Zhang G, Salathe M, Wanner A, Sandhaus RA, Baier H, Chest 2009 135 600 608 10.1378/chest.08-1129 19017884
11. Relapsing polychondritis: case report and literature review. Pol K, Jarosz M, Pol Arch Med Wewn 2009 119 680 683 19847147
12. The voice of 12,000 patients.Experiences and expectations of rare disease patients on diagnosis and care in Europe. A report based on the EurordisCare2 and EurordisCare3 Survey, [ http://www.eurordis.org/IMG/pdf/voice-12000- patients/EURORDISCARE-FULLBOOKr.pdf ].
13. DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population. Lenato GM, Lastella P, Di Giacomo MC, Resta N, Suppressa P, Pasculli G, Sabb C, Guanti G, Hum Mutat 2006 27 213 214 16429407
14. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H, Am J Med Genet 2000 6 66 67 (Pubitemid 30127562)
15. Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. Sabb C, Pasculli G, Lenato GM, Suppressa P, Lastella P, Memeo M, Dicuonzo F, Guanti G, J Thromb Haemost 2007 5 1149 1157 10.1111/j.1538-7836. 2007.02531.x 17388964 (Pubitemid 46902115)
16. A language and environment for statistical computing. R Development Core Team: R, Vienna, Austria: R Foundation for Statistical Computing; ISBN 3- 900051-07-0[ http://www.R-project.org ].
17. Hereditary hemorrhagic telangiectasia. Guttmacher AE, Marchuk DA, White RI, N Engl J Med 1995 5 918 924
18. A rare and misdiagnosed bleeding disorder: hereditary hemorrhagic telangiectasia. Sabb C, J Thromb Haemost 2005 3 2201 2210 10.1111/j.1538-7836. 2005.01345.x 15892861 (Pubitemid 41727198)
19. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, et al. J Med Genet 2011 48 73 87 10.1136/jmg.2009.069013 19553198
20. Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia. Cohen JH, Faughnan ME, Letarte M, Vandezande K, Kennedy SJ, Krahn MD, Am J Med Genet A 2005 30 153 160 (Pubitemid 41262682)
21. The need for an interdisciplinary network of investigations on HHT. Pasculli G, Sallustio G, Sabb C, Curr Pharm Des 2006 12 1249 1251 10.2174/138161206776361327 16611107 (Pubitemid 44082132)
22. Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents. Folz BJ, Zoll B, Alfke H, Toussaint A, Maier RF, Werner JA, Eur Arch Otorhinolaryngol 2006 263 53 61 10.1007/s00405-005-0956-8 15976991 (Pubitemid 43004712)
23. Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Cirulli A, Liso A, D'Ovidio F, Mestice A, Pasculli G, Gallitelli M, Rizzi R, Specchia G, Sabb C, Acta Haematol 2003 110 29 32 10.1159/000072411 12975554 (Pubitemid 37140401)
24. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. Sadick H, Riedel F, Naim R, Goessler U, Hörmann K, Hafner M, Lux A, Haematologica 2005 90 818 828 15951295
25. Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia. Giordano P, Lenato GM, Pierucci P, Suppressa P, Altomare M, Del Vecchio G, Di Bitonto G, De Mattia D, Guanti G, Sabb C, J Pediatr Hematol Oncol 2009 31 577 582 10.1097/MPH.0b013e3181a1c104 19636272
26. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Cymerman U, Vera S, Pece-Barbara N, Bourdeau A, White RI, Dunn J, Letarte M, Pediatr Res 2000 47 24 35 10.1203/00006450-200001000-00008 10625079 (Pubitemid 30038888)
27. Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes. Sanz-Rodriguez F, Fernandez-L A, Zarrabeitia R, Perez-Molino A, Ramírez JR, Coto E, Bernabeu C, Botella LM, Clin Chem 2004 50 2003 2011 10.1373/clinchem.2004.035287 15375013 (Pubitemid 39425836)
28. Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT). Ojeda-Fernandez L, Barrios L, Rodriguez-Barbero A, Recio-Poveda L, Bernabeu C, Botella LM, Clin Chim Acta 2010 20 411494 411499
29. Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia. Bernhardt BA, Zayac C, Pyeritz RE, Genet Med 2011 13 812 820 10.1097/GIM.0b013e31821d2e6d 21637104
30. Mutation study of Spanish patients with Hereditary Hemorrhagic Telangiectasia and expression analysis of Endoglin and ALK1. Fernandez-Lopez A, Sanz-Rodriguez F, Zarrabeitia R, Perez-Molino A, Morales C, Restrepo CM, Ramirez JR, Coto E, Lenato GM, Bernabeu C, Botella LM, Hum Mutat 2006 27 295 16470590
31. Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. McDonald JE, Miller FJ, Hallam SE, Nelson L, Marchuk DA, Ward KJ, Am J Med Genet 2000 93 320 327 10.1002/1096-8628(20000814)93:4<320:: AID-AJMG12>3.0.CO;2-R 10946360 (Pubitemid 30497453)
32. HHT Foundation International: HHT Awareness Video. [ http://hht.org/2012/ 01/hht-awareness-video/ ]
33. Cushing's syndrome: why is diagnosis so difficult? Aron DC, Rev Endocr Metab Disord 2010 11 105 116 10.1007/s11154-010-9127-3 20217244
34. "Osler's phenomenon": misdiagnosing Cushing's syndrome. De P, Evans LM, Scanlon MF, Davies JS, Postgrad Med J 2003 79 594 596 10.1136/pmj.79.936.594 14612605 (Pubitemid 37445257)